HPV vaccine for all

被引：46

作者：

Michels, Karin B. ^{[1
,2
]}

zur Hausen, Harald ^{[3
]}

机构：

[1] Harvard Univ, Sch Med,Obstet & Gynecol Epidemiol Ctr, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA

[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA

[3] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany

来源：

LANCET | 2009年 / 374卷 / 9686期

关键词：

HUMAN-PAPILLOMAVIRUS; PARTICLE VACCINE; UNITED-STATES; PREVALENCE; INFECTION; CANCER; WOMEN; DNA;

D O I：

10.1016/S0140-6736(09)61247-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：268 / 270

页数：3

共 12 条

[1] Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women
Block, Stan L.
Nolan, Terry
Sattler, Carlos
Barr, Eliav
Giacoletti, Katherine E. D.
Marchant, Colin D.
Castellsague, Xavier
Rusche, Steven A.
Lukac, Suzanne
Bryan, Janine T.
Cavanaugh, Paul F., Jr.
Reisinger, Keith S.
[J]. PEDIATRICS, 2006, 118 (05) : 2135 - 2145
[2] A NEW TYPE OF PAPILLOMAVIRUS DNA, ITS PRESENCE IN GENITAL CANCER BIOPSIES AND IN CELL-LINES DERIVED FROM CERVICAL-CANCER
BOSHART, M
GISSMANN, L
IKENBERG, H
KLEINHEINZ, A
SCHEURLEN, W
HAUSEN, HZ
[J]. EMBO JOURNAL, 1984, 3 (05) : 1151 - 1157
[3] Prevalence of HPV infection among females in the United States
Dunne, Eileen F.
Unger, Elizabeth R.
Sternberg, Maya
McQuillan, Geraldine
Swan, David C.
Patel, Sonya S.
Markowitz, Lauri E.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (08): : 813 - 819
[4] Prevalence of HPV infection among men: A systematic review of the literature
Dunne, Eileen F.
Nielson, Carrie M.
Stone, Katherine M.
Markowitz, Lauri E.
Giuliano, Anna R.
[J]. JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (08) : 1044 - 1057
[5] A PAPILLOMAVIRUS DNA FROM A CERVICAL-CARCINOMA AND ITS PREVALENCE IN CANCER BIOPSY SAMPLES FROM DIFFERENT GEOGRAPHIC REGIONS
DURST, M
GISSMANN, L
IKENBERG, H
ZURHAUSEN, H
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (12): : 3812 - 3815
[6] Einstein MH, 2009, 25 INT PAP C MALM SW
[7] Model for assessing human papillomavirus vaccination strategies
Elbasha, Elamin H.
Dasbach, Erik J.
Insinga, Ralph P.
[J]. EMERGING INFECTIOUS DISEASES, 2007, 13 (01) : 28 - 41
[8] The health and economic burden of genital warts in a set of private health plans in the United States
Insinga, RP
Dasbach, EJ
Myers, ER
[J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 (11) : 1397 - 1403
[9] Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
Paovonen, J.
Naud, P.
Salmeron, J.
Wheeler, C. M.
Chow, S-N
Apter, D.
Kitchener, H.
Castellsague, X.
Teixeira, J. C.
Skinner, S. R.
Hedrick, J.
Jaisamrarn, U.
Limson, G.
Garland, S.
Szarewski, A.
Romanowski, B.
Aoki, F. Y.
Schwarz, T. F.
Poppe, W. A. J.
Bosch, F. X.
Jenkins, D.
Hardt, K.
Zahaf, T.
Descamps, D.
Struyf, F.
Lehtinen, M.
Dubin, G.
[J]. LANCET, 2009, 374 (9686) : 301 - 314
[10] Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: Improving upon nature
Schwarz, Tino F.
Leo, Oberdan
[J]. GYNECOLOGIC ONCOLOGY, 2008, 110 (03) : S1 - S10

← 1 2 →